{"product_id":"13th-biennial-thyroid-update-2021","title":"13th Biennial Thyroid Update 2021","description":"\u003ch3\u003e\u003cstrong\u003e13th Biennial Thyroid Update 2021\u003c\/strong\u003e\u003c\/h3\u003e\u003cbr\u003e13th Biennial Thyroid Update 2021 has transitioned to a virtual meeting! We are delighted to bring you updates in thyroid conditions such as hypothyroidism, hyperthyroidism, thyroid nodules and thyroid cancers. This program aims to clarify the important issues surrounding the diagnosis and management of these common thyroid disorders. Guidelines on hypothyroidism, thyroid nodules as well as well-differentiated, medullary thyroid cancer and anaplastic thyroid cancer have been recently updated.\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThis conference will utilize and encourage the use of a multidisciplinary approach to educate clinicians about current and controversial issues in thyroid disease and will provide an opportunity for providers to become familiar with the key elements of the updated guidelines and incorporate them into their clinical practice.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eInclude: 15 videos + 1 pdf, size: 3.17 GB\u003c\/h4\u003e\u003cbr\u003eTarget Audience: Endocrinology, Diabetes and Metabolism, Nuclear Medicine, Oncology, Otolaryngology, Pathology, Radiation Oncology, Radiology, Surgery\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e13th Biennial Thyroid Update 2021.pdf\u003c\/li\u003e\n\u003cli\u003eSession I and Session II Panel Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eSession I Intro and Thyroid-Associated Ophthalmopathy From Bench to Bedside.mp4\u003c\/li\u003e\n\u003cli\u003eSession I Management of Hypothyroidism Beyond the Levothyroxine You Know.mp4\u003c\/li\u003e\n\u003cli\u003eSession I Modern Evaluation and Management of Thyroid Nodules.mp4\u003c\/li\u003e\n\u003cli\u003eSession I Thyroid Disorders and Pregnancy.mp4\u003c\/li\u003e\n\u003cli\u003eSession II Intro and The Future of Thyroid Surgery.mp4\u003c\/li\u003e\n\u003cli\u003eSession III and IV Panel Discussion and Closing Remarks.mp4\u003c\/li\u003e\n\u003cli\u003eSession III Debate Active Surveillance vs. I-131 Therapy for Low Intermediate Risk Papillary Thyroid Cancer – Douglas Van Nostrand.mp4\u003c\/li\u003e\n\u003cli\u003eSession III Debate Active Surveillance vs. I-131 Therapy for Low Intermediate Risk Papillary Thyroid Cancer – Leonard Wartofsky.mp4\u003c\/li\u003e\n\u003cli\u003eSession III Debate Active Surveillance vs. I-131 Therapy for Low Intermediate Risk Papillary Thyroid Cancer – R. Michael Tuttle.mp4\u003c\/li\u003e\n\u003cli\u003eSession III Graves Disease The Nuclear Medicine Perspective.mp4\u003c\/li\u003e\n\u003cli\u003eSession III Intro and Graves Disease The Medical Perspective.mp4\u003c\/li\u003e\n\u003cli\u003eSession IV Advances in the Treatment of Anaplastic Thyroid Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSession IV Intro and Precision Medicine in the Treatment of Differentiated Thyroid Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSession IV Targeting RET in Medullary Thyroid Cancer.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 class=\"activitysectionbold\"\u003eObjectives\u003c\/h2\u003e\n\u003cdiv\u003eUpon completing this activity, participants will be able to:\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eEvaluate and compare the available molecular tests for thyroid nodules to determine which patients require thyroid surgery and which patients can be monitored.\u003c\/li\u003e\n\u003cli\u003eIncorporate an interdisciplinary approach to the diagnosis and management of patients with thyroid disease.\u003c\/li\u003e\n\u003cli\u003eEvaluate and select newly approved targeted oral chemotherapy agents for the treatment of locally advanced or metastatic thyroid cancer refractory to radioiodine therapy.\u003c\/li\u003e\n\u003cli\u003eUtilize stratified risk assessment for thyroid cancer.\u003c\/li\u003e\n\u003cli\u003eIdentify proper thyroid cancer patient selection for monitoring, lobectomy, or total thyroidectomy.\u003c\/li\u003e\n\u003cli\u003eImplement American Thyroid Association Guideline recommendations for evaluation and management of thyroid nodules and thyroid cancer.\u003c\/li\u003e\n\u003cli\u003eEvaluate when to use tissue genotyping in the management of advanced thyroid cancer.\u003c\/li\u003e\n\u003cli\u003eIntegrate a team-based approach in the care of patients with thyroid cancer.\u003c\/li\u003e\n\u003cli\u003eIdentify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with thyroid cancer.\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954357702754,"sku":"MED-AMB01947","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/13th-Biennial-Thyroid-Update-2021.jpg?v=1779374652","url":"https:\/\/meducourse.com\/products\/13th-biennial-thyroid-update-2021","provider":"Meducourse","version":"1.0","type":"link"}